Corsera Health is changing the face of human health—by predicting and preventing cardiovascular disease before it begins
Location: United States
Total raised: $80M
Investors 1
| Date | Name | Website |
| 17.10.2025 | Population... | population... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.01.2026 | Series A | $80M | Forbion |
Mentions in press and media 4
| Date | Title | Description |
| 11.01.2026 | Corsera Health Secures $80M for Cardiovascular Prevention | Corsera Health secured an $80 million Series A. This capital fuels the company's mission to revolutionize cardiovascular health. It advances preventive RNAi medicines, targeting key drivers: LDL cholesterol and high blood pressure. These on... |
| 08.01.2026 | Corsera Health: $80 Million Series A Raised To Advance Cardiovascular Disease Prediction | Corsera Health announced it raised an oversubscribed $80 million Series A to advance its cardiovascular disease prediction-and-prevention strategy and to fund development of once-annual preventive RNAi medicines targeting the two primary dr... |
| 07.01.2026 | Corsera Health Raises $80M in Series A Financing | Corsera Health, Inc., a Boston, MA-based clinical-stage company leading the future of cardiovascular health through prediction and prevention, raised $80m in Series A financing. The round was led by Forbion and Population Health Partners wi... |
| - | Corsera Health | “Corsera Health is changing the face of human health—by predicting and preventing cardiovascular disease before it begins” |